Evidence map›Paper›PMID 35324962›Full record

ArticlePloS one2022

Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets.

Daiju Ueda, Akira Yamamoto, Naoyoshi Onoda, Tsutomu Takashima, Satoru Noda, Shinichiro Kashiwagi, Tamami Morisaki, Shinya Fukumoto, Masatsugu Shiba, Mina Morimura and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Use of AI Histopathology in Breast Cancer Diagnosis.Medicina (Kaunas, Lithuania) · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Daiju UedaDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0002-3878-3616
Akira YamamotoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Naoyoshi OnodaDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Tsutomu TakashimaDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Satoru NodaDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0002-8150-5152
Shinichiro KashiwagiDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Tamami MorisakiDepartment of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Shinya FukumotoDepartment of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Masatsugu ShibaDepartment of Gastroenterology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Mina MorimuraDepartment of General Practice, Osaka City University Hospital, Osaka, Japan.
Taro ShimonoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0001-5847-6587
Ken KageyamaDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Hiroyuki TatekawaDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0002-8050-4895
Kazuki MuraiDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0003-2738-8781
Takashi HonjoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0001-7961-1266
Akitoshi ShimazakiDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Daijiro KabataDepartment of Medical Statistics, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Yukio MikiDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Osaka City University · JPOsaka City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective of this study was to develop and validate a state-of-the-art, deep learning (DL)-based model for detecting breast cancers on mammography.

methodsMammograms in a hospital development dataset, a hospital test dataset, and a clinic test dataset were retrospectively collected from January 2006 through December 2017 in Osaka City University Hospital and Medcity21 Clinic. The hospital development dataset and a publicly available digital database for screening mammography (DDSM) dataset were used to train and to validate the RetinaNet, one type of DL-based model, with five-fold cross-validation. The model's sensitivity and mean false positive indications per image (mFPI) and partial area under the curve (AUC) with 1.0 mFPI for both test datasets were externally assessed with the test datasets.

resultsThe hospital development dataset, hospital test dataset, clinic test dataset, and DDSM development dataset included a total of 3179 images (1448 malignant images), 491 images (225 malignant images), 2821 images (37 malignant images), and 1457 malignant images, respectively. The proposed model detected all cancers with a 0.45-0.47 mFPI and had partial AUCs of 0.93 in both test datasets.

conclusionsThe DL-based model developed for this study was able to detect all breast cancers with a very low mFPI. Our DL-based model achieved the highest performance to date, which might lead to improved diagnosis for breast cancer.

Indexed as

Breast NeoplasmsDeep LearningEarly Detection of CancerFemaleHumansMammographyRetrospective Studies

Identifiers

PMID35324962
PMCPMC8947392
OpenAlexW4220700630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.